Search research articles
Contact Us
Filters
Showing results (431-440 of 441) with videos related to
Page
of 45
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
February 23, 2002
2-Arylindoles as gonadotropin releasing hormone (GnRH) antagonists: optimization of the tryptamine side chain
Jonathan R Young, Song X Huang, Thomas F Walsh, et al.
Journal of Medicinal Chemistry
|
March 25, 2009
Discovery of novel tricyclic full agonists for the G-protein-coupled niacin receptor 109A with minimized flushing in rats
Hong C Shen, Fa-Xiang Ding, Qiaolin Deng, et al.
Circulation
|
August 18, 2025
An Aberrant Resurgence of Endogenous Retroviruses Prompts Myocarditis and Heart Failure
Junhao Xiong, Shasha Zhang, Zilong Geng, et al.
Journal of Medicinal Chemistry
|
November 13, 2007
Discovery of biaryl anthranilides as full agonists for the high affinity niacin receptor
Hong C Shen, Fa-Xiang Ding, Silvi Luell, et al.
Journal of Medicinal Chemistry
|
July 31, 2008
3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): a partial agonist of the nicotinic acid receptor, G-protein coupled receptor 109a, with antilipolytic but no vasodilatory activity in mice
Graeme Semple, Philip J Skinner, Tawfik Gharbaoui, et al.
Journal of Medicinal Chemistry
|
February 27, 2010
Discovery of a biaryl cyclohexene carboxylic acid (MK-6892): a potent and selective high affinity niacin receptor full agonist with reduced flushing profiles in animals as a preclinical candidate
Hong C Shen, Fa-Xiang Ding, Subharekha Raghavan, et al.
Physiological Genomics
|
November 22, 2012
11β-HSD1 inhibition reduces atherosclerosis in mice by altering proinflammatory gene expression in the vasculature
Mingjuan J Luo, Rolf Thieringer, Martin S Springer, et al.
The Journal of Experimental Medicine
|
August 17, 2005
11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice
Anne Hermanowski-Vosatka, James M Balkovec, Kang Cheng, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
April 28, 2025
Organocatalytic Switches of DNA Glycosylase OGG1 Catalyze a Highly Efficient AP-Lyase Function
Mario Kehler, Kaixin Zhou, Aurino M Kemas, et al.
Science Translational Medicine
|
August 24, 2012
Niacin lipid efficacy is independent of both the niacin receptor GPR109A and free fatty acid suppression
Brett Lauring, Andrew K P Taggart, James R Tata, et al.
Page
of 45
Search research articles
Search
Showing results (431-440 of 441) with videos related to
Sort By:
Page
of 45
Bioorganic & Medicinal Chemistry Letters
|
February 23, 2002
2-Arylindoles as gonadotropin releasing hormone (GnRH) antagonists: optimization of the tryptamine side chain
Jonathan R Young, Song X Huang, Thomas F Walsh, et al.
Journal of Medicinal Chemistry
|
March 25, 2009
Discovery of novel tricyclic full agonists for the G-protein-coupled niacin receptor 109A with minimized flushing in rats
Hong C Shen, Fa-Xiang Ding, Qiaolin Deng, et al.
Circulation
|
August 18, 2025
An Aberrant Resurgence of Endogenous Retroviruses Prompts Myocarditis and Heart Failure
Junhao Xiong, Shasha Zhang, Zilong Geng, et al.
Journal of Medicinal Chemistry
|
November 13, 2007
Discovery of biaryl anthranilides as full agonists for the high affinity niacin receptor
Hong C Shen, Fa-Xiang Ding, Silvi Luell, et al.
Journal of Medicinal Chemistry
|
July 31, 2008
3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): a partial agonist of the nicotinic acid receptor, G-protein coupled receptor 109a, with antilipolytic but no vasodilatory activity in mice
Graeme Semple, Philip J Skinner, Tawfik Gharbaoui, et al.
Journal of Medicinal Chemistry
|
February 27, 2010
Discovery of a biaryl cyclohexene carboxylic acid (MK-6892): a potent and selective high affinity niacin receptor full agonist with reduced flushing profiles in animals as a preclinical candidate
Hong C Shen, Fa-Xiang Ding, Subharekha Raghavan, et al.
Physiological Genomics
|
November 22, 2012
11β-HSD1 inhibition reduces atherosclerosis in mice by altering proinflammatory gene expression in the vasculature
Mingjuan J Luo, Rolf Thieringer, Martin S Springer, et al.
The Journal of Experimental Medicine
|
August 17, 2005
11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice
Anne Hermanowski-Vosatka, James M Balkovec, Kang Cheng, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
April 28, 2025
Organocatalytic Switches of DNA Glycosylase OGG1 Catalyze a Highly Efficient AP-Lyase Function
Mario Kehler, Kaixin Zhou, Aurino M Kemas, et al.
Science Translational Medicine
|
August 24, 2012
Niacin lipid efficacy is independent of both the niacin receptor GPR109A and free fatty acid suppression
Brett Lauring, Andrew K P Taggart, James R Tata, et al.
Page
of 45